Clinical Trial Update: The Effects of Neprilysin on Glucagon-like Peptide-1 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update studying the effects of neprilysin on glucagon-like peptide-1 in diabetes and heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes
• Heart Failure

Snippet

Sponsor: Nicolai Jacob Wewer Albrechtsen | Conditions: Diabetes, Heart Failure | Phase 4 | Status: COMPLETED